Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model

Virology

Volumn 332, Issue 1, 2005, Pages 337-346

  Zerboni, Leigh ^a   Hinchliffe, Stewart ^a   Sommer, Marvin H ^a   Ito, Hideki ^a   Besser, Jaya ^a   Stamatis, Shaye ^a   Cheng, Jason ^a   DiStefano, Daniel ^b   Kraiouchkine, Nikolai ^b   Shaw, Alan ^b   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

IE62 localization; Oka strain; SCIDhu mice; Varicella vaccine; Varicella zoster virus

Indexed keywords

LIVE VACCINE; PROTEIN C; VARICELLA ZOSTER VACCINE;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CHIMERA; CONTROLLED STUDY; COSMID; EPIDERMIS CELL; GENOME ANALYSIS; HERPES VIRUS; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; VARICELLA ZOSTER VIRUS; VIRUS ATTENUATION; VIRUS GENOME; VIRUS ISOLATION; VIRUS PLAQUE; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE; XENOGRAFT;

ANIMALS; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MICE; MICE, SCID; RECOMBINATION, GENETIC; SKIN TESTS; TRANSPLANTATION, HETEROLOGOUS; VACCINES, ATTENUATED; VIRAL VACCINES; VIRULENCE;

HERPESVIRIDAE; HUMAN HERPESVIRUS 3;

EID: 19944431399     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.10.047     Document Type: Article

References (39)

1. T. Argaw, J.I. Cohen, M. Klutch, K. Lekstrom, T. Yoshikawa, Y. Asano, and P.R. Krause Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates J. Infect. Dis. 181 2000 1153 1157
2. A.M. Arvin Varicella vaccine: genesis, efficacy, and attenuation Virology 284 2001 153 158
3. A.M. Arvin Varicella-Zoster virus D.N. Knipe P.M. Howley Fields Virology 2001 Lippincott- Raven Publishers Philadelphia 2731 2768
4. J. Besser, M.H. Sommer, L. Zerboni, C.P. Bagowski, H. Ito, J. Moffat, C.C. Ku, and A.M. Arvin Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse J. Virol. 77 2003 5964 5974
5. M. Broyer, M.J. Tete, G. Guest, M.F. Gagnadoux, and C. Rouzioux Varicella and zoster in children after kidney transplantation: long-term results of vaccination Pediatrics 99 1997 35 39
6. J.E. Cohen, and S.E. Straus Varicella-zoster virus and its replication D.M. Knipe P.M. Howley Fields Virology 2001 Lippincott- Raven Publishers Philadelphia 2707 2730
7. J.I. Cohen, and K.E. Seidel Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro Proc. Natl. Acad. Sci. U.S.A. 90 1993 7376 7380
8. A.J. Davison, and J.E. Scott The complete DNA sequence of varicella-zoster virus J. Gen. Virol. 67 1986 1759 1816
9. B. Faga, W. Maury, D.A. Bruckner, and C. Grose Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome Virology 280 2001 1 6
10. A.A. Gershon Live-attenuated varicella vaccine Infect. Dis. Clin. North Am. 15 2001 65 81
11. Y. Gomi, T. Imagawa, M. Takahashi, and K. Yamanishi Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity J. Med. Virol. 61 2000 497 503
12. Y. Gomi, H. Sunamachi, H., Y. Mori, K. Nagaike, M. Takahashi, and K. Yamanishi Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus J. Virol. 76 2002 11447 11459
13. H. Ito, M.H. Sommer, L. Zerboni, H. He, D. Boucaud, J. Hay, W. Ruyechan, and A.M. Arvin Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo J. Virol. 77 2003 489 498
14. C.E. Johnson, T. Stancin, D. Fattlar, L.P. Rome, and M.L. Kumar A long-term prospective study of varicella vaccine in healthy children Pediatrics 100 1997 761 766
15. H. Kamiya, T. Kato, M. Isaji, S. Torigoe, K. Oitani, M. Ito, T. Ihara, M. Sakurai, and M. Takahashi Immunization of acute leukemic children with a live varicella vaccine (Oka strain) Biken J. 27 1984 99 102
16. G.W. Kemble, P. Annunziato, O. Lungu, R.E. Winter, T.A. Cha, S.J. Silverstein, and R.R. Spaete Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells J. Virol. 74 2000 11311 11321
17. P.G. Kennedy, E. Grinfeld, and J.W. Gow Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia Proc. Natl. Acad. Sci. U.S.A. 95 1998 4658 4662
18. P.R. Kinchington, J.K. Hougland, A.M. Arvin, W.T. Ruyechan, and J. Hay The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles J. Virol. 66 1992 359 366
19. P.R. Kinchington, K. Fite, and S.E. Turse Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase J. Virol. 74 2000 2265 2277
20. C.M. Koropchak, S.M. Solem, P.S. Diaz, and A.M. Arvin Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization J. Virol. 63 1989 2392 2395
21. C.C. Ku, J.A. Padilla, C. Grose, E.C. Butcher, and A.M. Arvin Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers J. Virol. 76 2002 11425 11433
22. C.C. Ku, L. Zerboni, H. Ito, B.S. Graham, M. Wallace, and A.M. Arvin Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha J. Exp. Med. 200 2004 917 925
23. S. Mallory, M. Sommer, and A.M. Arvin Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking J. Virol. 71 1997 8279 8288
24. S. Mallory, M. Sommer, and A.M. Arvin Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids J. Infect. Dis. 1998 S22 S26
25. J.F. Moffat, M.D. Stein, H. Kaneshima, and A.M. Arvin Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice J. Virol. 69 1995 5236 5242
26. J.F. Moffat, L. Zerboni, P.R. Kinchington, C. Grose, and H. Kaneshima Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse J. Virol. 72 1998 965 974
27. J.F. Moffat, L. Zerboni, M.H. Sommer, T.C. Heineman, J.I. Cohen, H. Kaneshima, and A.M. Arvin The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse Proc. Natl. Acad. Sci. U.S.A. 95 1998 11969 11974
28. J. Moffat, H. Ito, M. Sommer, S. Taylor, and A.M. Arvin Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells J. Virol. 76 2002 8468 8471
29. J. Moffat, C. Mo, J.J. Cheng, M.H. Sommer, L. Zerboni, S. Stamatis, and A.M. Arvin Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T cell tropism in vivo J. Virol. 78 22 2004 12406 12415
30. T. Niizuma, L. Zerboni, M.H. Sommer, H. Ito, S. Hinchliffe, and A.M. Arvin Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model J. Virol. 77 2003 6062 6065
31. T. Ozaki, T. Ichikawa, Y. Matsui, H. Kondo, T. Nagai, Y. Asano, K. Yamanishi, and M. Takahashi Lymphocyte-associated viremia in varicella J. Med. Virol. 19 1986 249 253
32. S.A. Plotkin, S.E. Starr, K. Connor, and D. Morton Zoster in normal children after varicella vaccine J. Infect. Dis. 159 1989 1000 1001
33. M.L. Quinlivan, A.A. Gershon, S.P. Steinberg, and J. Breuer Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from a single clone of virus J. Infect. Dis. 10 2004 793 796
34. B. Sato, H. Ito, S. Hinchliffe, M.H. Sommer, L. Zerboni, and A.M. Arvin Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo J. Virol. 77 2003 5607 5620
35. A. Sauerbrei, J. Prager, U. Hengst, F. Zintl, and P. Wutzler Varicella vaccination in children after bone marrow transplantation Bone Marrow Transplant 20 1997 381 383
36. W. Soong, J.C. Schultz, A.C. Patera, M.H. Sommer, and J.I. Cohen Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates J. Virol. 74 2000 1864 1870
37. M. Takahashi, T. Otsuka, Y. Okuno, Y. Asano, T. Yazaki, and S. Isomura Live vaccine used to prevent the spread of varicella in children in hospital Lancet 2 1974 1288 1290
38. J. von Bokay Uber den a tiologischen Zusammenhang der Varizellen mit gewissen Fallen von Herpes Zoster Wein. Klin. Wochenschr. 22 1909 1323 1326
39. C.J. White Clinical trials of varicella vaccine in healthy children Infect. Dis. Clin. North Am. 10 1996 595 608